Decision

Seedling Life Science Ventures LLC v. Pfizer Canada Inc., 2017 FC 826

Proth. Tabib - 2017-09-12

Read full decision. Automatically generated summary:

Seedling Life Science Ventures LLC (“Seedlings”) is a small corporation in the business of health care-related research and product development. It considers that Pfizer Canada Inc. (“Pfizer’), a large pharmaceutical company, infringes one of its patents and it has accordingly commenced this patent infringement action. ... Prior to issuing its statement of claim, Seedlings sought out and entered into a Litigation Funding Agreement (“LFA”) with Bentham IMF Capital Limited (“Bentham”) ... Seedlings and Bentham thus presented this motion to the Court seeking the “approval” of the LFA. ... As mentioned, there are no procedural requirements for the approval of a party’s funding agreement outside of class proceedings and no substantive grounds upon which this Court might assume jurisdiction to enquire into or determine the validity of the LFA in the context of the action as instituted.

Decision relates to:

  • T-608-17 - SEEDLINGS LIFE SCIENCE VENTURES,LLC V. PFIZER CANADA INC.

 

Canadian Intellectual Property